Rapamycin Press Logo
  • Home
  • Publication ETHICS
  • Editorial Policies
  • SCIENTIFIC INTEGRITY
  • About +
    • Mission
    • Affiliations
    • Conferences
  • Engage +
    • Subscribe
    • Contact
    • Departments
  • News +
    • Press Releases
    • Author Spotlights
    • Blogs
    SUBMIT A MANUSCRIPT
Rapamycin Press Logo
Rapamycin Press LLC dba Impact Journals
  • Home
  • Publication Ethics
  • Editorial Policies
  • SCIENTIFIC INTEGRITY
  • About
    • Mission
    • Affiliations
    • Conferences
  • Engage
    • Subscribe
    • Contact
    • Departments
  • News
    • Press Releases
    • Author Spotlights
    • Blogs
SUBMIT A MANUSCRIPT

top

News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

New Drug Combination Redefines First-Line Treatment for Advanced Urothelial Cancer

Oncotarget

July 1, 2025

New Lipid-Based Aging Clock Reveals Faster Brain Aging in Autism, Schizophrenia, and Down Syndrome

Aging

July 1, 2025

HER2-Mutated NSCLC in Brazil Shows Diverse Genetic Patterns and Treatment Gaps

Oncotarget

June 27, 2025

New Research Finds Telomere Shortening Not Consistent Across Premature Aging Disorders

Aging

June 25, 2025

WIN International Molecular Tumor Board Recommends Tailored Treatment for Advanced Colorectal Cancer

Oncotarget

June 24, 2025
1 2 3 … 126 Next »
ENTER

Journals

  • Aging
  • Oncotarget
  • Oncoscience
  • Genes & Cancer

About

  • Mission
  • Publication Ethics and Malpractice
  • Affiliations
  • Conferences

Engage

  • Subscribe
  • Contact
  • Departments
Aging
Oncotarget
Oncoscience
Genes & Cancer
By using our site you are giving us permission to use cookies. This website collects cookies to deliver a better user experience, and to analyze our website traffic and performance. Personal data is not collected.
Privacy policy
Terms of service
© 2025 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC